INTERRELATION OF COVID-19 AND HYPERTENSION; A REVIEW STUDY

Saleha Haidari; Zahra Rahimi; Sayed Muslim Musavi; Marina Hakimi

INTERRELATION OF COVID-19 AND HYPERTENSION; A REVIEW STUDY

Authors

Saleha Haidari Pharm D, Pharmacology Department, Rabia Balkhy University, Kabul, Afghanistan
Zahra Rahimi Pharm D, Pharmacology Department, Rabia Balkhy University, Kabul, Afghanistan
Sayed Muslim Musavi Pharm D, Microbiology Department, Shifa University, Kabul, Afghanistan
Marina Hakimi Pharm D, Plant Manager, Moon Bright pharmaceutical industry, Kabul, Afghanistan

Keywords:

SARS-CoV-2, Hypertension, RAAS inhibitors

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a respiratory tract virus that causes Coronavirus disease (COVID-19). The virus originated in Wuhan, China, in December 2019 and has spread to the world. Most patients reported having at least one comorbidities with COVID-19 upon hospital admission. Hypertension, diabetes, chronic obstructive pulmonary disease, obesity, and cardiovascular diseases are among the most commonly reported. Comorbidities are contributing to acute disease prognosis and increased risk of severe symptoms. This review intends to understand how hypertension affect the disease’s prognosis and how severe the outcome can be expected

Downloads

Published

2023-06-21

How to Cite

Saleha Haidari, Zahra Rahimi, Sayed Muslim Musavi, & Marina Hakimi. (2023). INTERRELATION OF COVID-19 AND HYPERTENSION; A REVIEW STUDY. World Bulletin of Public Health, 23, 164-172. Retrieved from https://scholarexpress.net/index.php/wbph/article/view/2933